Inhibition of LDHB triggers DNA damage and increases cisplatin sensitivity in pleural mesothelioma

September 9, 2025 | Comments Off on Inhibition of LDHB triggers DNA damage and increases cisplatin sensitivity in pleural mesothelioma

Oncogenesis 2025 August 11 [Link] Yantang Lin, Christelle Dubey, Tereza Losmanova, Samuel Oevgü Yasmin, Jean-Louis Reymond, Ren-Wang Peng, Haibin Deng, Patrick Dorn, Thomas Michael Marti Abstract Pleural mesothelioma (PM) is…

Inhibition of LDHB triggers DNA damage and increases cisplatin sensitivity in pleural mesothelioma

September 8, 2025 | Comments Off on Inhibition of LDHB triggers DNA damage and increases cisplatin sensitivity in pleural mesothelioma

Oncogenesis 2025 August 11 [Link] Yantang Lin, Christelle Dubey, Tereza Losmanova, Samuel Oevgü Yasmin, Jean-Louis Reymond, Ren-Wang Peng, Haibin Deng, Patrick Dorn, Thomas Michael Marti Abstract Pleural mesothelioma (PM) is…

First-line nivolumab plus ipilimumab in pleural mesothelioma: Efficacy and safety data from the real-world MesoNet study

September 5, 2025 | Comments Off on First-line nivolumab plus ipilimumab in pleural mesothelioma: Efficacy and safety data from the real-world MesoNet study

Lung Cancer 2025 August 5 [Link] Rajiv Shah, Eva L Buchmeier, Hans-Georg Kopp, Daniel C Christoph 4, Frank Griesinger, Martin Reck, Petra Hoffknecht, Jonas Kuo, Nikolaj Frost, Christian Grohé, Martin…

Single-cell RNA-sequencing as a potential approach for studying intratumor heterogeneity in pleural mesothelioma

September 4, 2025 | Comments Off on Single-cell RNA-sequencing as a potential approach for studying intratumor heterogeneity in pleural mesothelioma

Lung Cancer 2025 August 5 [Link] Ania Alay, Raúl Marín, Elisabet Aliagas, Mireia Gausachs, Max Ruiz-Gil, Ivan Macia, Amaia Ojanguren, Susana Padrones, Eduard Dorca, Jesús Brenes, Ramón Palmero, Víctor Moreno,…

Prospective Analysis of Mesotheliomas in Subjects with BAP1 Cancer Syndrome: Clinical Characteristics and Epigenetic Correlates of Disease

September 3, 2025 | Comments Off on Prospective Analysis of Mesotheliomas in Subjects with BAP1 Cancer Syndrome: Clinical Characteristics and Epigenetic Correlates of Disease

Journal of Thoracic Oncology 2025 August 5 [Link] Xinwei Wu, Frank-Villa Hernandez, Haitao Wang, Ruihong Wang, Stephanie Shiffka, Niharika Shah, Shamus R Carr, Chuong D Hoang, Andrew M Blakely, Alexandra…

Pipeline to evaluate YAP-TEAD inhibitors indicates TEAD inhibition represses NF2-mutant mesothelioma

September 2, 2025 | Comments Off on Pipeline to evaluate YAP-TEAD inhibitors indicates TEAD inhibition represses NF2-mutant mesothelioma

Life Science Alliance 2025 July 31 [Link] Richard Cunningham, Siyang Jia, Krishna Purohit, Michaela Noskova Fairley 1, Marcin K Maniak, Yue Lin, Ning Sze Hui, Rebecca E Graham, Adriano G…

Effectiveness of Surgical Treatment on Survival of Patients with Malignant Pleural Mesothelioma

August 29, 2025 | Comments Off on Effectiveness of Surgical Treatment on Survival of Patients with Malignant Pleural Mesothelioma

Cancers 2025 July 16 [Link] Renata Báez-Saldaña, María Esther Marmolejo-Torres, Marco Antonio Iñiguez-García, Aída Jiménez-Corona, Juan Alberto Berrios-Mejía Abstract Background: The benefit of surgery for malignant pleural mesothelioma is highly…

Towards a new approach in pleural mesothelioma: Perioperative immunotherapy and its implications

August 28, 2025 | Comments Off on Towards a new approach in pleural mesothelioma: Perioperative immunotherapy and its implications

Critical Reviews in Oncology/Hematology 2025 July 23 [Link] Paolo Ambrosini, Alessia Stanzi, Giuseppe Lo Russo, Piergiorgio Solli, Mario Occhipinti Abstract Pleural mesothelioma is a rare malignancy that has historically had…

Enhanced efficacy of immune checkpoint inhibitors with OK-432 in malignant pleural mesothelioma: A case report

August 27, 2025 | Comments Off on Enhanced efficacy of immune checkpoint inhibitors with OK-432 in malignant pleural mesothelioma: A case report

Molecular and Clinical Oncology 2025 July 3 [Link] Kazuki Yamada, Takehiro Uemura, Aya Mukai, Tatsuya Tanaka, Ippei Sakakibara, Keima Ito, Yuta Mori, Kensuke Fukumitsu, Satoshi Fukuda, Yoshihiro Kanemitsu, Tomoko Tajiri,…

Neoadjuvant immunotherapy in a solitary, isolated peritoneal mesothelioma involving the abdominal wall: a case report

August 26, 2025 | Comments Off on Neoadjuvant immunotherapy in a solitary, isolated peritoneal mesothelioma involving the abdominal wall: a case report

Immunotherapy 2025 July [Link] Parsa Charkhchi, Ryan Le, Taryn E Cazzolli, Raina R Flores, Roberto A Martinez, Supreet Kaur, Mio Kitano Abstract Mesothelioma is a rare neoplasm with a minority…

Categories